USPTO serial 79291194
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,625
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devasena Reddy
Devasena Reddy HM LAW GROUP LLP5655 Silver Creek Valley Road, #850San Jose, CA 95138UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; Biological preparations for use in industry and science; Biological preparations for use in manufacture; Biological preparations for use in science; Biological preparation for use in cell cultures other than for medical or veterinary use; Blood culture media being cell culture media for scientific use; Biochemicals, namely, precursors for in vitro genetic engineering use; Chemical preparations for use in DNA analysis for scientific purposes, other than medical; Enzymes for use as biochemical catalysts for scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific use; Diagnostic test kits for scientific use, comprised of reagents, processing chemicals; Biochemicals for use in industry and science; Molecular biological reagents for use in industry and science; Plasmids for use in industry and science; Chromosomes being DNA molecules, DNA polymerase for use in industry and science; Diagnostic test kits for use in science, comprised of patch preparations being diagnostic reagents | ACTIVE | — |
| 005 | Preparations for detecting genetic predispositions for medical purposes; Biological implants, namely, a vital processed human or animal connective tissue; Biological bone, skin tissue for implantation; Biological adjuvants for medical purposes; Biological reagents for medical use; Biological preparations for the treatment of cancer; Mixed biological preparations for medical purposes for the treatment of cancer and the prevention and treatment of infectious diseases; Biological tissue cultures for medical purposes; Bone growth media consisting of biological materials for medical purposes; Human plasma protein being blood plasma; Blood plasma; Blood components being cord blood, blood, blood plasma for medical purposes; Blood substitutes for human, veterinary use; Blood protein fractions for medical purposes, namely, for use in cell culture products and diagnostic applications; DNA synthesis inhibitors for medical use; Chemical preparations for use in DNA analysis for medical purposes for the treatment of infectious diseases and cancer; Cells for medical use; Diagnostic medical reagents for medical use in diagnosing inflammatory, infections, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; Diagnostic test kits for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological endocrine, autoimmune and genetic diseases and cancer, comprised of reagents, processing chemicals and patches; Medical diagnostic test kits comprised of medical diagnostic reagents for detecting pathogens in the environment | ACTIVE | — |
| 009 | DNA microarrays; DNA chips; Biochip sensors for research and scientific purposes; Bioreactor for cell culturing; Laboratory equipment, namely, laboratory apparatus and laboratory instruments, namely, homogenizers, bottle top filters used the purification of tissue culture media, radiation devices in the nature of ultraviolet, visible, or infra-red light boxes for the analysis of bodily fluids, pre-packed columns for use in chemical synthesis, pre-packed columns for use in separation and purification, spectroscopes, cupels; Apparatus for sieve tests, the detection of analytes in samples and the identification of the sample type, together with measurement pattern and kits comprised of laboratory analyzers for analyzing bodily fluids for building and screening of molecular systems as well as parts for it, namely research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, urine analyzers, immunoassay analyzers, hematology analyzers | ACTIVE | — |
| 042 | Genetic research; Genetic fingerprinting for scientific or medical research purposes; Scientific research relating to genetics; Scientific research in the field of genetics and genetic engineering; Biological laboratory services; Biological cloning services; Biological research, clinical research in the field of infectious disease, cancer, radiology, chemotherapy, coronary artery bypass surgery and medical research; Scientific laboratory services, namely, services of a chemical and/or biological laboratory; Blood analysis services; Genetic engineering services; DNA screening for scientific research purposes; Research and development in the field of microorganisms and cells; Scientific services relating to the isolation and cultivation of human tissues and cells; Research and development services for third parties in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental testing processes and industrial quality control processes; Chemical sieve analysis; Scientific and technological services, namely, research and design services in the field of diagnostic chemicals; Industrial analysis in the nature of analysis of industrial fluids; Industrial research in the field of diagnostic chemicals; Services of an industrial designer; Quality control for others; Providing user authentication services using biometric hardware and software technology for e-commerce transactions, secure entry and exit door access; Design and development of computer hardware and software; Research being product research and scientific research in the area of textile dyes; Research being product research, scientific research, biomedical research in the area of textile dyes consisting of bacteria | ACTIVE | — |
| 044 | Medical and health assessment services relating to naked DNA, genetics and genetic testing for medical purposes; Genetic counselling; Blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; Medical diagnostic services being execution of tests and analysis; Execution of medical tests for diagnostic or treatment purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 4, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 4, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 9, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 12, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 11, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |